Products
Platform
Research
Market
Learn
Compare Bandhan BSE Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.02 | 1.87 |
NAV | ₹10.25 | ₹40.39 |
Fund Started | 21 Aug 2024 | 25 Jun 2018 |
Fund Size | ₹17.74 Cr | ₹6226.82 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.02
1.87
NAV
₹10.25
₹40.39
Fund Started
21 Aug 2024
25 Jun 2018
Fund Size
₹17.74 Cr
₹6226.82 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 4.18% | 6.93% |
3 Year | - | 27.23% |
5 Year | - | 20.44% |
1 Year
4.18%
6.93%
3 Year
-
27.23%
5 Year
-
20.44%
Holding Analysis
Equity | 100.07% | 97.55% |
Cash | -0.07% | 2.45% |
Equity
100.07%
97.55%
Cash
-0.07%
2.45%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.81% |
Cipla Ltd. | 6.37% |
Max Healthcare Institute Ltd. | 6.27% |
Apollo Hospitals Enterprise Ltd. | 5.67% |
Dr. Reddy's Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.52% |
Fortis Healthcare Ltd. | 3.84% |
Lupin Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 2.87% |
Laurus Labs Ltd. | 2.49% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.58% |
Dr. Reddy's Laboratories Ltd. | 9.10% |
Divi's Laboratories Ltd. | 8.75% |
Aurobindo Pharma Ltd. | 8.25% |
Cipla Ltd. | 6.92% |
Lupin Ltd. | 5.43% |
Alkem Laboratories Ltd. | 4.05% |
Biocon Ltd. | 3.11% |
Gland Pharma Ltd. | 2.97% |
Mankind Pharma Ltd. | 2.95% |
Fund Manager
Name | Nemish Sheth | Dharmesh Kakkad |
Start Date | 13 Feb 2025 | 23 Feb 2021 |
Name
Nemish Sheth
Dharmesh Kakkad
Start Date
13 Feb 2025
23 Feb 2021
About Fund
Description | The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 21 Aug 2024 | 25 Jun 2018 |
Description
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
21 Aug 2024
25 Jun 2018